Viva Biotech Announced 2022 Annual Results:

/PRNewswire/ -- On March 30, 2023, Viva Biotech Holdings (1873.HK) announced that during the year ended December 31, 2022 (the "Reporting Period"), the revenue...

Related Keywords

Japan ,Taiwan ,United States ,Qiantang ,Guangdong ,China ,To Ride ,Ibaraki ,Australia ,Chengdu ,Sichuan ,Canada ,Germany ,Hangzhou ,Zhejiang ,France ,United Kingdom ,Zhoupu ,Shanghai ,Suzhou ,Jiangsu ,America ,Cheney Mao ,Our Computational Chemistry Department ,Viva Biotech Holdings ,Shanghai Supercomputing Center ,Gross Profit ,One Stop Platform Continuously ,Significant Competitive Edges ,Steady Growth Outlook ,Long Run ,Reporting Period ,Langhua Pharmaceutical ,Incubation Business ,Investment Funds ,North America ,Computational Chemistry Department ,Faladi Road ,Qiantang New District ,Supercomputing Center ,Chief Executive Officer ,Viva Biotech ,